The Glycemic Effect of Taking a Supplementation of Orange Juice With Fibers
NCT ID: NCT00966862
Last Updated: 2009-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
INTERVENTIONAL
2009-09-30
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This will be a double-blind parallel controlled study. Each subject will serve as his own control.
Study population will include 10 subjects. The subjects will be randomly assigned to receive one of two juices in occasion, in two visits. Each drink will be containing orange juice with\\without fibers.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Other: Dietary Fibers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 60 \>18 years
* Written informed consent
* Consumers of orange drinks: freshly squeezed juices, commercial pasteurized juices and / or orange soft drinks
* Regular eating pattern
Exclusion Criteria
* diabetes,
* cancer,
* C.O.P.D.,
* metabolic syndrome,
* overweight,
* kidney failure,
* heart disease,
* osteoporosis.
* Antibiotic treatment in the last 4 weeks
* Subjects on regular probiotic or prebiotic supplementation, unless they do 2 weeks of wash out.
* Subjects with intestinal disorders such as: IBD, IBS, celiac, colon cancer.
* Subjects after intestinal surgery.
* Use of medicines for lowering cholesterol (simvastatin), sugar control
* Pregnancy
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nachum Vaisman, Prof'
Role: PRINCIPAL_INVESTIGATOR
Suorasky Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suorasky Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nachum Vaisman, Prof'
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TASMC-09-NV-237-CTIL
Identifier Type: -
Identifier Source: org_study_id